合計 50 件の最近のインサイダー取引記録が記録されています Adicet Bio, Inc. (ACET), 内訳は 31 件の買い および 17 件の売り. インサイダー買い総額は $19.63M インサイダー売り総額は $744.93K.
最近活動のある主要インサイダーには Schor Chen, Harvey Brian Nicholas, Healey Don. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — ACET
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-03-25 |
Schor Chen |
President & CEO |
RSU 付与（制限付株式） |
468,555 |
$6.81 |
$3.19M |
468,555 |
| 2026-03-25 |
Harvey Brian Nicholas |
Chief Financial Officer |
RSU 付与（制限付株式） |
43,361 |
$6.81 |
$295.29K |
43,361 |
| 2026-03-25 |
Healey Don |
Chief Technology Officer |
RSU 付与（制限付株式） |
43,361 |
$6.81 |
$295.29K |
43,361 |
| 2026-03-25 |
Aftab Blake |
Chief Scientific Officer |
RSU 付与（制限付株式） |
72,555 |
$6.81 |
$494.1K |
72,555 |
| 2026-03-25 |
Maltzman Julia D. |
Chief Medical Officer |
RSU 付与（制限付株式） |
72,555 |
$6.81 |
$494.1K |
72,555 |
| 2026-01-24 |
Schor Chen |
President & CEO |
RSU 源泉徴収 |
1,755 |
$8.44 |
$14.81K |
6,820 |
| 2026-01-24 |
Harvey Brian Nicholas |
Chief Financial Officer |
RSU 源泉徴収 |
546 |
$8.44 |
$4.61K |
5,145 |
| 2026-01-24 |
Healey Don |
Chief Technology Officer |
RSU 源泉徴収 |
535 |
$8.44 |
$4.52K |
3,452 |
| 2026-01-24 |
Aftab Blake |
Chief Scientific Officer |
RSU 源泉徴収 |
535 |
$8.44 |
$4.52K |
2,981 |
| 2025-10-08 |
Orbimed Advisors Llc |
10 Percent Owner |
情報に基づく買い |
3,500,000 |
$1.00 |
$3.5M |
4,490,254 |
| 2025-06-11 |
Dubin Steve |
Director |
RSU 付与（制限付株式） |
5,900 |
- |
- |
22,700 |
| 2025-06-11 |
Chodakewitz Jeffrey |
Director |
RSU 付与（制限付株式） |
5,900 |
- |
- |
17,700 |
| 2025-06-11 |
Sinclair Andrew |
Director |
RSU 付与（制限付株式） |
5,900 |
- |
- |
17,700 |
| 2025-06-11 |
Klickstein Lloyd |
Director |
RSU 付与（制限付株式） |
26,400 |
$0.78 |
$20.59K |
26,400 |
| 2025-06-11 |
Peng Katie |
Director |
RSU 付与（制限付株式） |
5,900 |
- |
- |
11,800 |
| 2025-04-17 |
Grissinger Michael |
Officer |
不明 |
- |
- |
- |
- |
| 2025-04-17 |
Grissinger Michael |
Director |
RSU 付与（制限付株式） |
70,200 |
$0.53 |
$36.91K |
70,200 |
| 2025-01-31 |
Schor Chen |
President & CEO |
RSU 付与（制限付株式） |
763,829 |
$0.89 |
$675.99K |
763,829 |
| 2025-01-31 |
Harvey Brian Nicholas |
Chief Financial Officer |
RSU 付与（制限付株式） |
324,040 |
$0.89 |
$286.78K |
324,040 |
| 2025-01-31 |
Healey Don |
Chief Technology Officer |
RSU 付与（制限付株式） |
275,000 |
$0.89 |
$243.38K |
275,000 |
| 2025-01-31 |
Aftab Blake |
Chief Scientific Officer |
RSU 付与（制限付株式） |
275,000 |
$0.89 |
$243.38K |
275,000 |
| 2025-01-31 |
Maltzman Julia D. |
Chief Medical Officer |
RSU 付与（制限付株式） |
750,000 |
$0.89 |
$663.75K |
750,000 |
| 2025-01-24 |
Schor Chen |
President & CEO |
RSU 源泉徴収 |
28,101 |
$0.92 |
$25.9K |
137,201 |
| 2025-01-24 |
Harvey Brian Nicholas |
Chief Financial Officer |
RSU 源泉徴収 |
8,752 |
$0.92 |
$8.07K |
91,048 |
| 2025-01-24 |
Healey Don |
Chief Technology Officer |
RSU 源泉徴収 |
8,560 |
$0.92 |
$7.89K |
63,769 |
| 2025-01-24 |
Aftab Blake |
Chief Scientific Officer |
RSU 源泉徴収 |
6,270 |
$0.92 |
$5.78K |
56,241 |
| 2025-01-13 |
Maltzman Julia D. |
Officer |
不明 |
- |
- |
- |
- |
| 2024-08-21 |
Dubin Steve |
Director |
株式返還 |
26,400 |
$2.14 |
$56.5K |
- |
| 2024-08-21 |
Gordon Carl L |
10 Percent Owner |
株式返還 |
26,400 |
$2.14 |
$56.5K |
- |
| 2024-08-21 |
Kauffman Michael |
Director |
株式返還 |
26,400 |
$2.14 |
$56.5K |
- |
| 2024-08-21 |
Chodakewitz Jeffrey |
Director |
株式返還 |
26,400 |
$2.14 |
$56.5K |
- |
| 2024-08-21 |
Sinclair Andrew |
Director |
株式返還 |
26,400 |
$2.14 |
$56.5K |
- |
| 2024-08-21 |
Jakobovits Aya |
Director |
株式返還 |
26,400 |
$2.14 |
$56.5K |
- |
| 2024-08-21 |
Peng Katie |
Director |
株式返還 |
70,200 |
$2.14 |
$150.23K |
- |
| 2024-08-19 |
Klickstein Lloyd |
Director |
処分 |
80,000 |
$2.14 |
$171.2K |
- |
| 2024-08-19 |
Klickstein Lloyd |
Director |
RSU 付与（制限付株式） |
70,200 |
$1.55 |
$108.81K |
70,200 |
| 2024-06-05 |
Dubin Steve |
Director |
RSU 付与（制限付株式） |
5,900 |
- |
- |
16,800 |
| 2024-06-05 |
Gordon Carl L |
10 Percent Owner |
RSU 付与（制限付株式） |
5,900 |
- |
- |
11,800 |
| 2024-06-05 |
Schor Chen |
President & CEO |
RSU 付与（制限付株式） |
1,770,427 |
$2.53 |
$4.48M |
1,770,427 |
| 2024-06-05 |
Kauffman Michael |
Director |
情報に基づく売り |
5,900 |
$1.43 |
$8.44K |
5,900 |
| 2024-06-05 |
Harvey Brian Nicholas |
Chief Financial Officer |
RSU 付与（制限付株式） |
374,829 |
$2.53 |
$948.32K |
374,829 |
| 2024-06-05 |
Chodakewitz Jeffrey |
Director |
RSU 付与（制限付株式） |
5,900 |
- |
- |
11,800 |
| 2024-06-05 |
Healey Don |
Chief Technology Officer |
RSU 付与（制限付株式） |
271,595 |
$2.53 |
$687.14K |
271,595 |
| 2024-06-05 |
Sinclair Andrew |
Director |
RSU 付与（制限付株式） |
5,900 |
- |
- |
11,800 |
| 2024-06-05 |
Jakobovits Aya |
Director |
RSU 付与（制限付株式） |
5,900 |
- |
- |
11,800 |
| 2024-06-05 |
Galimi Francesco |
SVP & Chief Medical Officer |
RSU 付与（制限付株式） |
375,077 |
$2.53 |
$948.94K |
375,077 |
| 2024-06-05 |
Aftab Blake |
Chief Scientific Officer |
RSU 付与（制限付株式） |
336,911 |
$2.53 |
$852.38K |
336,911 |
| 2024-06-05 |
Peng Katie |
Director |
RSU 付与（制限付株式） |
5,900 |
- |
- |
5,900 |
| 2024-01-25 |
Orbimed Advisors Llc |
10 Percent Owner |
情報に基づく買い |
242,200 |
$2.40 |
$581.28K |
990,254 |
| 2024-01-25 |
Gordon Carl L |
10 Percent Owner |
情報に基づく買い |
242,200 |
$2.40 |
$581.28K |
990,254 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
